ActoFactor™ Recombinant Human Nephroblastoma Overexpressed Gene
- Specification
 - Q & A
 - Customer Review
 
Cat.No.
CSC-CTK0381
Description
NOV is a member of the CCN family of secreted cysteine rich regulatory proteins. The full length NOV protein contains four structural domains that confer distinct, and sometimes opposing, biological activities. Elevated expression of NOV is associated with certain tumors, including Wilm's tumor and most nephroblastomas. However, in other tumor types and certain cancer cell lines, increased tumorgenicity and proliferation is correlated with decreased NOV expression. Additionally, NOV induces cell adhesion and cell migration by signaling through specific cell surface integrins and by binding to heparin sulfate proteoglycans and to fibulin 1C. NOV has also been reported to exert proangiogenic activities. Recombinant human NOV is a 36.2 kDa protein containing 331 amino acid residues. It is composed of four distinct structural domains (modules); the IGF binding protein (IGFBP) domain, the von Willebrand Factor C (VWFC) domain, the Thrombospondin type-I (TSP type-1) domain, and a C-terminal cysteine knot-like domain (CTCK).
Species
                                Human
                            Product Overview
                                Human NOV expressed in E.coli
                            Molecular Mass
                                36.2 kDa
                            Size
                                CAT# CSC-CTK0381-20 (20 μg); CAT# CSC-CTK0381-100 (100 μg)
                            Expression System
                                E.coli
                            Purity
                                Greater than 95% as determined by SDS-PAGE and HPLC analysis.
                            Activity
                                Determined by a cell proliferation assay using BALB/c 3T3 cells. The expected ED50 for this effect is 1.0-2.0 μg/ml.
                            Endotoxin Level
                                Less than 1 EU/μg.
                            Formulation
                                Lyophilized from a sterile-filtered solution in 10 mM sodium phosphate (pH 7.5).
                            Reconstitution
                                Please centrifuge product before opening vial. The lyophilized protein should be reconstituted with distilled, sterile water to a concentration of 0.1-1.0 mg/ml. For further dilution, carrier protein (0.1% BSA or HSA) should be added to avoid loss of bioactivity.
                            Storage & Stability
                                The lyophilized protein, though stable at room temperature for up to 3 weeks, is best stored desiccated at -20°C. Reconstituted protein should be used immediately or stored long-term in undiluted working aliquots at -20°C. For long-term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid repeated freeze-thaw cycles.
                            Citation Guidance
                        
                            If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no.
                            
                                If your paper has been published, please click here
                                to submit the PubMed ID of your paper to get a coupon.
                            
                        
                    Ask a Question
Write your own review